Elizabeth R. Gerstner

Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma

Tracy T. Batchelor, Dan G. Duda, Emmanuelle di Tomaso et al. · Journal of Clinical Oncology · 2010 · 513 citations · Full text

Detection of 2-Hydroxyglutarate in <i>IDH</i> -Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy

Ovidiu C. Andronesi, Grace S. Kim, Elizabeth R. Gerstner et al. · Science Translational Medicine · 2012 · 412 citations · Full text

Residual Convolutional Neural Network for the Determination of <i>IDH</i> Status in Low- and High-Grade Gliomas from MR Imaging

Ken Chang, Harrison X. Bai, Hao Zhou et al. · Clinical Cancer Research · 2017 · 378 citations · Full text

A Serologic Marker of Paraneoplastic Limbic and Brain-Stem Encephalitis in Patients with Testicular Cancer

Raymond Voltz, Sakir H. Gultekin, Myrna R. Rosenfeld et al. · New England Journal of Medicine · 1999 · 374 citations · Full text

Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation

Tracy T. Batchelor, Elizabeth R. Gerstner, Kyrre E. Emblem et al. · Proceedings of the National Academy of Sciences · 2013 · 335 citations · Full text

Tumor Innervation, Blood Perfusion, High-grade Gliomas +22